123 related articles for article (PubMed ID: 24512726)
1. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
Shuliang S; Lei C; Guangwu J; Changjie L
Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
[TBL] [Abstract][Full Text] [Related]
2. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
Wen M; Kwon Y; Wang Y; Mao JH; Wei G
Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
[TBL] [Abstract][Full Text] [Related]
5. Effects of ubiquitin-conjugating enzyme 2C on invasion, proliferation and cell cycling of lung cancer cells.
Tang XK; Wang KJ; Tang YK; Chen L
Asian Pac J Cancer Prev; 2014; 15(7):3005-9. PubMed ID: 24815438
[TBL] [Abstract][Full Text] [Related]
6.
Liu Y; Zhao R; Chi S; Zhang W; Xiao C; Zhou X; Zhao Y; Wang H
Mol Cancer Res; 2020 Feb; 18(2):204-215. PubMed ID: 31662448
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
Xie C; Powell C; Yao M; Wu J; Dong Q
Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.
Zhang Z; Liu P; Wang J; Gong T; Zhang F; Ma J; Han N
Med Oncol; 2015 May; 32(5):149. PubMed ID: 25832867
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer.
Wu X; Long X; Ma C; Cheuk YC; Hu M; Hu J; Jiang H
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430352
[TBL] [Abstract][Full Text] [Related]
11. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
Xiong Y; Lu J; Fang Q; Lu Y; Xie C; Wu H; Yin Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30914455
[TBL] [Abstract][Full Text] [Related]
12. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
Ieta K; Ojima E; Tanaka F; Nakamura Y; Haraguchi N; Mimori K; Inoue H; Kuwano H; Mori M
Int J Cancer; 2007 Jul; 121(1):33-8. PubMed ID: 17354233
[TBL] [Abstract][Full Text] [Related]
13. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.
Wang H; Zhang C; Rorick A; Wu D; Chiu M; Thomas-Ahner J; Chen Z; Chen H; Clinton SK; Chan KK; Wang Q
Cancer Res; 2011 Jul; 71(14):4866-76. PubMed ID: 21593191
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C.
Li W; Wang F; Wang X; Xu W; Liu F; Hu R; Li S
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23645. PubMed ID: 38348716
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
Han Q; Zhou C; Liu F; Xu G; Zheng R; Zhang X
Oncol Rep; 2015 Aug; 34(2):877-83. PubMed ID: 26062455
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.
Bose MV; Gopisetty G; Selvaluxmy G; Rajkumar T
Int J Radiat Biol; 2012 Sep; 88(9):629-34. PubMed ID: 22694363
[TBL] [Abstract][Full Text] [Related]
17. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
Wang R; Song Y; Liu X; Wang Q; Wang Y; Li L; Kang C; Zhang Q
Int J Oncol; 2017 Apr; 50(4):1116-1126. PubMed ID: 28260026
[TBL] [Abstract][Full Text] [Related]
18. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.
Zhang S; You X; Zheng Y; Shen Y; Xiong X; Sun Y
J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548081
[TBL] [Abstract][Full Text] [Related]
19. Role of UBE2C in Brain Cancer Invasion and Dissemination.
Domentean S; Paisana E; Cascão R; Faria CC
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958776
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.
Zhang Y; Li X; Gong Y; Du D; Chen H; Liu L; Cheng Z
Medicine (Baltimore); 2023 May; 102(20):e33834. PubMed ID: 37335710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
